FATE THERAPEUTICS INC

Ticker: FATE CUSIP: 31189P102 Class: COM

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 24,636 Value ($000) $41 Avg Close $2.52 Range $1.55 - $3.50

Q2 2024

Shares 24,223 Value ($000) $79 Avg Close $4.38 Range $3.10 - $7.35

Q4 2023

Shares 38,230 Value ($000) $143 Avg Close $2.36 Range $1.63 - $4.13

Q3 2023

Shares 17,337 Value ($000) $37 Avg Close $3.31 Range $1.99 - $5.08

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	24,636	$41	$2.52	$1.55 - $3.50
Q2 2024	24,223	$79	$4.38	$3.10 - $7.35
Q4 2023	38,230	$143	$2.36	$1.63 - $4.13
Q3 2023	17,337	$37	$3.31	$1.99 - $5.08